ERBB2 and cancer: For example, patients treated initially with human epidermal growth factor receptor 2 (HER2) therapy were noted to have a paradoxically high rate of brain metastases by unmasking CNS disease as a sanctuary site and providing improved cancer control elsewhere [12].